Strides receives USFDA approval for Flucytosine Capsules

The product is a generic version of Ancobon Capsules, 250 mg and 500 mg, of Bausch Health US, LLC, the Bengaluru- headquartered pharmaceutical company said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Vn2cFV
via IFTTT